A phase I, open-label, dose-finding, safety, tolerability, and exploratory trial of intraperitoneal THEO-260 in patients with high-grade serous or endometrioid ovarian cancer. This is an ASCO Meeting ...
If you experience urinary tract infections (UTIs) that keep coming back, you’re not alone. About 30 to 40 percent of women develop recurrent UTIs, which is when you have at least two UTIs in six ...
AMES, Iowa – Iowa State University’s Digital Ag Innovation team, in partnership with Terraplex Ag, will host a two-day Drone Workshop designed to prepare participants for the Federal Aviation ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Washington and Lee University Office of General Counsel Code of Policies Technology Use and Safety Protocol for Unmanned Aerial Systems Governed by FAA Part 107 (Drones) The educational use of ...
AMES, Iowa – Iowa State University’s Digital Ag Innovation Lab, in partnership with Terraplex Ag, will host a two-day Drone Workshop designed to prepare participants for the Federal Aviation ...
An objective response rate of 50.5% was observed with raludotatug deruxtecan across all dose levels in these patients in the phase 2 part of REJOICE-Ovarian01 Phase 3 part of REJOICE-Ovarian01 to ...
Please provide your email address to receive an email when new articles are posted on . ACOG recommends concurrent sexual partner therapy with antimicrobial agents for some patients with recurrent ...
A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery—the ...
SAN FRANCISCO, September 28, 2025 — A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results